V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Environmental, Social and Governance Co-op

Regulatory Compliance & EthicsConfirmed live in the last 24 hours
Internship · Winter 2027Boston, MA, USA

About the Job

Requirements

  • Must be an undergraduate or graduate student pursuing a degree in sustainability, business, government, or communications, or have demonstrated interest in health, medicine, or public policy.
  • Have excellent research and data analysis skills.
  • Be organized and efficient, with clear communication and writing skills.
  • Demonstrate the ability to collaborate and work with a variety of colleagues.
  • Have legal authorization to work in the United States now and in the future.
  • Be enrolled in an advanced degree program if graduating before June 2027.
  • Be available to work full-time, 40 hours per week, from January through June 2027.

Responsibilities

  • Support data collection for Vertex’s annual Corporate Responsibility Report.
  • Support mandatory external disclosures, including country-specific disclosures.
  • Assist with the development and entry of Vertex’s annual CDP submission.
  • Track current and emerging global ESG regulations, standards, and reporting frameworks, including coordinating submission requirements and due dates across Vertex global entities.
  • Benchmark the industry, including positions taken on select topics, and provide recommendations when appropriate.
  • Prepare presentation decks to support key meetings.

Desired Qualifications

  • Project management experience to support various workstreams is a plus.
  • Experience with process documentation is a plus.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs